Matches in Wikidata for { <http://www.wikidata.org/entity/Q91770051> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- Q91770051 description "artículu científicu espublizáu n'abril de 2019" @default.
- Q91770051 description "scientific article published on 26 April 2019" @default.
- Q91770051 description "wetenschappelijk artikel" @default.
- Q91770051 description "наукова стаття, опублікована 26 квітня 2019" @default.
- Q91770051 name "Concomitant anti-platelet therapy in warfarin-treated patients undergoing cardiac rhythm device implantation: A secondary analysis of the BRUISE CONTROL trial" @default.
- Q91770051 name "Concomitant anti-platelet therapy in warfarin-treated patients undergoing cardiac rhythm device implantation: A secondary analysis of the BRUISE CONTROL trial" @default.
- Q91770051 type Item @default.
- Q91770051 label "Concomitant anti-platelet therapy in warfarin-treated patients undergoing cardiac rhythm device implantation: A secondary analysis of the BRUISE CONTROL trial" @default.
- Q91770051 label "Concomitant anti-platelet therapy in warfarin-treated patients undergoing cardiac rhythm device implantation: A secondary analysis of the BRUISE CONTROL trial" @default.
- Q91770051 prefLabel "Concomitant anti-platelet therapy in warfarin-treated patients undergoing cardiac rhythm device implantation: A secondary analysis of the BRUISE CONTROL trial" @default.
- Q91770051 prefLabel "Concomitant anti-platelet therapy in warfarin-treated patients undergoing cardiac rhythm device implantation: A secondary analysis of the BRUISE CONTROL trial" @default.
- Q91770051 P1433 Q91770051-7CAAC845-EB0D-422C-8AE7-9C51C43563A1 @default.
- Q91770051 P1476 Q91770051-A6FB8605-E735-4E77-81A8-7CDC5F7AC13B @default.
- Q91770051 P2093 Q91770051-0BEF72C4-59F1-4CB5-98DF-7DA64FBB7F41 @default.
- Q91770051 P2093 Q91770051-1FCD64CD-12E9-4A08-B30B-6D4306970927 @default.
- Q91770051 P2093 Q91770051-333AB550-3112-4278-900F-6B0081FFEC36 @default.
- Q91770051 P2093 Q91770051-3B71EF9C-AACD-4E3C-B29B-FFCA793CD6CB @default.
- Q91770051 P2093 Q91770051-43FF690D-59A0-4BC5-BE07-0D00EE8494A8 @default.
- Q91770051 P2093 Q91770051-5B7F3943-570F-48F0-BD48-32B1E83910C2 @default.
- Q91770051 P2093 Q91770051-5BDDBA07-0DC2-4DC7-BAD5-87FF586D3F4A @default.
- Q91770051 P2093 Q91770051-63B41A5B-F9F1-44B3-A1BA-19571CBB376D @default.
- Q91770051 P2093 Q91770051-69307F6C-F608-40C9-8C18-0E15CCA90044 @default.
- Q91770051 P2093 Q91770051-720321F1-0EFA-493E-8693-172AC574FAEB @default.
- Q91770051 P2093 Q91770051-7A90E758-7B96-40C5-83B5-1B84C6A124D0 @default.
- Q91770051 P2093 Q91770051-7C25D66C-E361-42BC-A2D3-F0B218338190 @default.
- Q91770051 P2093 Q91770051-999EE4DA-0B0C-418C-882D-B2D64256B280 @default.
- Q91770051 P2093 Q91770051-A3486DB4-70D3-48A8-AD91-06914E5A4A09 @default.
- Q91770051 P2093 Q91770051-AA0FF34B-053E-4F84-B9BC-D26AD18EA41F @default.
- Q91770051 P2093 Q91770051-AC170074-4130-4411-9059-3AE0E028986B @default.
- Q91770051 P2093 Q91770051-B16DD4FF-1421-4F1E-8FD5-E8464EAD2EFD @default.
- Q91770051 P2093 Q91770051-B5278BC5-21A0-4764-93EA-88C376E0BA9B @default.
- Q91770051 P2093 Q91770051-C748A15B-10A7-4B5C-B52E-C128364DD47F @default.
- Q91770051 P2093 Q91770051-D8BBFE0B-D689-4EB7-B79D-46105EC6DB27 @default.
- Q91770051 P2093 Q91770051-FFE18B6E-61FF-4772-B231-1B5ED8DF2E01 @default.
- Q91770051 P304 Q91770051-2056CF97-22A3-4F24-B158-14E64ADE74F4 @default.
- Q91770051 P31 Q91770051-E9A8FC9C-B0B9-45AF-B1AC-EE7012FD7252 @default.
- Q91770051 P356 Q91770051-D69DC8CA-C7F5-42F6-8908-E860790DAB79 @default.
- Q91770051 P478 Q91770051-EFDA064C-1F59-4531-A0B9-E6795CBD311B @default.
- Q91770051 P50 Q91770051-B3DC24BD-4828-40FD-A06C-153D5A8D8CAF @default.
- Q91770051 P577 Q91770051-8928C66E-703D-460E-9F27-642B46D29F00 @default.
- Q91770051 P698 Q91770051-49EFB4BD-F9EF-4CF3-922D-F31267C7C517 @default.
- Q91770051 P356 J.IJCARD.2019.04.066 @default.
- Q91770051 P698 31056413 @default.
- Q91770051 P1433 Q2357863 @default.
- Q91770051 P1476 "Concomitant anti-platelet therapy in warfarin-treated patients undergoing cardiac rhythm device implantation: A secondary analysis of the BRUISE CONTROL trial" @default.
- Q91770051 P2093 "Ahmed AlTurki" @default.
- Q91770051 P2093 "Andrew D Krahn" @default.
- Q91770051 P2093 "Atul Verma" @default.
- Q91770051 P2093 "BRUISE CONTROL Investigators" @default.
- Q91770051 P2093 "Benoit Coutu" @default.
- Q91770051 P2093 "Christopher S Simpson" @default.
- Q91770051 P2093 "Claus Rinne" @default.
- Q91770051 P2093 "Colette Seifer" @default.
- Q91770051 P2093 "David Birnie" @default.
- Q91770051 P2093 "Eugene Crystal" @default.
- Q91770051 P2093 "Felix Ayala-Paredes" @default.
- Q91770051 P2093 "George A Wells" @default.
- Q91770051 P2093 "Jeff S Healey" @default.
- Q91770051 P2093 "John Sapp" @default.
- Q91770051 P2093 "Kamran Ahmad" @default.
- Q91770051 P2093 "Katherine Kavanagh" @default.
- Q91770051 P2093 "Marcio Sturmer" @default.
- Q91770051 P2093 "Richard Leather" @default.
- Q91770051 P2093 "Satish Toal" @default.
- Q91770051 P2093 "Tiago L L Leiria" @default.
- Q91770051 P2093 "Vidal Essebag" @default.
- Q91770051 P304 "87-93" @default.
- Q91770051 P31 Q13442814 @default.
- Q91770051 P356 "10.1016/J.IJCARD.2019.04.066" @default.
- Q91770051 P478 "288" @default.
- Q91770051 P50 Q59100034 @default.
- Q91770051 P577 "2019-04-26T00:00:00Z" @default.
- Q91770051 P698 "31056413" @default.